The UAE has become the second country worldwide to approve Itvisma, a groundbreaking gene therapy for spinal muscular atrophy ...
Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...
Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and ...
Tata's 2026 Harrier and Safari debut petrol power, challenging diesel dominance in India's SUV market with the Hyperion ...
BSSC released the Bihar Sports Trainer Syllabus and Exam Pattern. Check the latest BSSC Sports Trainer Syllabus for all ...
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Emirates News Agency on MSN
UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Edex Live on MSN
UAE approves gene replacement therapy for wider SMA age group
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
Neuroscience now provides substantial evidence that meditation leads to measurable changes in brain structure and function, a ...
Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback